From the Donald W. Reynolds Cardiovascular Research Center (M.M.C., E.A.A., A.D., R.T., B.F., E.Y., J.Y.K., M.F., R.R., F.L.J., P.S.T., T.Q.), Division of Cardiovascular Medicine, Falk CVRC, Stanford University, Stanford, Calif; Agilent Technologies (D.X.F.D., A.T., A.B.-D., L.B., Z.Y.), Palo Alto, Calif; and Division of Cardiovascular and Medical Sciences (T.M., H.D.), University of Glasgow, Scotland. (At 2003-09-23)
